Remarkably, anti-PD-1 therapy after PAC-SABIs activation of macrophages produced the greatest tumor suppression effect and achieved a 60-day optimal survival rate of 57% (Fig. 8d). This evidence concerns the gene PDCD1 and neoplasm.